These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 29361103)
1. Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Rao BB; Lashner B; Kowdley KV Inflamm Bowel Dis; 2018 Jan; 24(2):269-276. PubMed ID: 29361103 [TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898 [TBL] [Abstract][Full Text] [Related]
3. Clinical management of inflammatory bowel disease in the organ recipient. Indriolo A; Ravelli P World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease in liver transplanted patients. Filipec Kanizaj T; Mijic M World J Gastroenterol; 2017 May; 23(18):3214-3227. PubMed ID: 28566881 [TBL] [Abstract][Full Text] [Related]
5. Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. Jørgensen KK; Lindström L; Cvancarova M; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM Scand J Gastroenterol; 2012 Sep; 47(8-9):1021-9. PubMed ID: 22577871 [TBL] [Abstract][Full Text] [Related]
6. Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: a systematic review and meta-analysis. Singh S; Edakkanambeth Varayil J; Loftus EV; Talwalkar JA Liver Transpl; 2013 Dec; 19(12):1361-9. PubMed ID: 24019127 [TBL] [Abstract][Full Text] [Related]
8. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes. Peverelle M; Paleri S; Hughes J; De Cruz P; Gow PJ Inflamm Bowel Dis; 2020 Nov; 26(12):1901-1908. PubMed ID: 31944235 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Palmela C; Peerani F; Castaneda D; Torres J; Itzkowitz SH Gut Liver; 2018 Jan; 12(1):17-29. PubMed ID: 28376583 [TBL] [Abstract][Full Text] [Related]
10. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. Åberg F; Abdulle A; Mäkelä A; Nissinen M Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092 [TBL] [Abstract][Full Text] [Related]
11. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821 [TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. Wang R; Leong RW World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052 [TBL] [Abstract][Full Text] [Related]
13. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis. Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966 [TBL] [Abstract][Full Text] [Related]
14. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. de Vries AB; Janse M; Blokzijl H; Weersma RK World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965 [TBL] [Abstract][Full Text] [Related]
15. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311 [TBL] [Abstract][Full Text] [Related]
16. Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. Sokol H; Cosnes J; Chazouilleres O; Beaugerie L; Tiret E; Poupon R; Seksik P World J Gastroenterol; 2008 Jun; 14(22):3497-503. PubMed ID: 18567077 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series. Altwegg R; Combes R; Laharie D; De Ledinghen V; Radenne S; Conti F; Chazouilleres O; Duvoux C; Dumortier J; Leroy V; Treton X; Durand F; Dharancy S; Nachury M; Goutorbe F; Lamblin G; Boivineau L; Peyrin-Biroulet L; Pageaux GP Dig Liver Dis; 2018 Jul; 50(7):668-674. PubMed ID: 29655972 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Singh S; Loftus EV; Talwalkar JA Am J Gastroenterol; 2013 Sep; 108(9):1417-25. PubMed ID: 23896954 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011. Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371 [TBL] [Abstract][Full Text] [Related]
20. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease. Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]